Cluster of differentiation 57 (CD57), also known as NK-1, is an antigen detectable in natural killer cells, some T-lymphocytes and normal peripheral blood mononuclear cells, myeloid cells, and a variety of polypeptides, lipids, and chondroitin sulfate proteoglycans. CD57 is indicated as a marker for tumors of neuroendocrine origin, including pheochromocytomas, paragangliomas, carcinoid tumor, and medulloblastomas, as well as various neural tumors including neuromas, neurofibromas, schwannomas, and granular cell tumors. CD57 is also detectable in ganglioneuroma and prostate carcinoma. Anti-CD57 is used to distinguish nodular lymphocyte-predominant Hodgkins lymphoma from T-cell/histiocyte-rich large B-cell lymphoma, nodular sclerosis Hodgkins disease, and follicular lymphoma.

Lanier LL, et al. J Immunol. 1983; 131:1789-96. Ritchie AW, et al. Clin Exp Immunol. 1983; 51:439-47. Caillaud JM, et al. Cancer Res. 1984; 44:4432-9. Tucker, et al. Cell Differ. 1984; 14:223-30. Abo T, et al. Cell Immunol. 1982; 73:376-84. Khoury T, et al. Int J Exp Pathol. 2011; 92:87-96. Boudova L, et al. Blood. 2003; 102:3753-8. Dabbs DJ. 2014: 324. Eiden SV, et al. Hum Pathol. 2002; 33:1126-32.